Unresectable Solid Tumor
Oncology·MeSH: Triple Negative Breast Neoplasms
4 drugs in development·2 companies·4 clinical trials
Drug Pipeline by Phase
Phase 3(2)
Phase 2(1)
| Drug | Company |
|---|---|
| Tuvusertib | Merck & Co., Inc. (MRK) |
Phase 1(1)
| Drug | Company |
|---|---|
| tcellvax | Regen BioPharma Inc (RGBPP) |
Compare drugs
Frequently asked questions
How many drugs are in development for Unresectable Solid Tumor?
BioSniper tracks 4 drugs in development for Unresectable Solid Tumor across 2 companies.
How many clinical trials target Unresectable Solid Tumor?
There are 4 clinical trials targeting Unresectable Solid Tumor tracked by BioSniper.
Deep-dive into Unresectable Solid Tumor
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis